
Bajaj Healthcare (BAJAJHCARE) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
1.5B
Gross Profit
605.0M
39.17%
Operating Income
42.3M
2.74%
Net Income
111.8M
7.24%
Balance Sheet Metrics
Total Assets
8.3B
Total Liabilities
3.7B
Shareholders Equity
4.7B
Debt to Equity
0.79
Cash Flow Metrics
Operating Cash Flow
7.5M
Free Cash Flow
5.0M
Revenue & Profitability Trend
Bajaj Healthcare Income Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Revenue | 5.4B | 4.7B | 6.5B | 6.8B | 6.6B |
Cost of Goods Sold | 2.9B | 2.6B | 3.9B | 5.0B | 4.6B |
Gross Profit | 2.6B | 2.1B | 2.6B | 1.8B | 1.9B |
Gross Margin % | 47.2% | 45.3% | 40.1% | 27.0% | 29.4% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | - | 154.1M | 214.0M | 70.7M | 61.4M |
Other Operating Expenses | 1.2B | 558.7M | 615.9M | 136.9M | 137.7M |
Total Operating Expenses | 1.2B | 712.7M | 829.9M | 207.6M | 199.1M |
Operating Income | 545.1M | 487.1M | 943.1M | 1.0B | 1.2B |
Operating Margin % | 10.0% | 10.3% | 14.6% | 15.3% | 18.5% |
Non-Operating Items | |||||
Interest Income | - | 3.3M | 4.3M | 1.7M | 1.7M |
Interest Expense | 279.0M | 290.5M | 164.0M | 110.0M | 83.4M |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | 460.1M | -166.8M | 781.8M | 896.8M | 1.2B |
Income Tax | 30.8M | -23.5M | 146.5M | 183.0M | 357.1M |
Effective Tax Rate % | 6.7% | 0.0% | 18.7% | 20.4% | 30.1% |
Net Income | 395.0M | -837.9M | 430.2M | 713.9M | 831.1M |
Net Margin % | 7.3% | -17.7% | 6.7% | 10.5% | 12.7% |
Key Metrics | |||||
EBITDA | 1.0B | 817.9M | 1.2B | 1.2B | 1.4B |
EPS (Basic) | ₹13.29 | ₹-30.36 | ₹15.59 | ₹25.87 | ₹30.11 |
EPS (Diluted) | ₹13.12 | ₹-30.36 | ₹15.59 | ₹25.87 | ₹30.11 |
Basic Shares Outstanding | 29718209 | 27598400 | 27598400 | 27598400 | 27598400 |
Diluted Shares Outstanding | 29718209 | 27598400 | 27598400 | 27598400 | 27598400 |
Income Statement Trend
Bajaj Healthcare Balance Sheet From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 26.0M | 21.7M | 177.2M | 19.8M | 142.4M |
Short-term Investments | 352.8M | 7.5M | 15.1M | 110.2M | 6.6M |
Accounts Receivable | 2.5B | 1.8B | 1.9B | 1.8B | 988.8M |
Inventory | 1.6B | 1.4B | 2.1B | 1.6B | 971.1M |
Other Current Assets | 339.6M | 423.1M | 512.2M | 1.0K | 474.4M |
Total Current Assets | 5.6B | 4.7B | 5.0B | 4.0B | 2.6B |
Non-Current Assets | |||||
Property, Plant & Equipment | 2.4B | 10.3M | 10.3M | 44.3M | 44.3M |
Goodwill | 14.0M | 18.1M | 13.9M | 0 | - |
Intangible Assets | 14.0M | 18.1M | 13.9M | - | - |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | - | 1.0K | -2.4M | 1.0K | -1.0K |
Total Non-Current Assets | 2.7B | 2.9B | 4.0B | 3.2B | 2.7B |
Total Assets | 8.3B | 7.6B | 9.0B | 7.2B | 5.3B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 954.7M | 894.3M | 847.5M | 1.0B | 689.5M |
Short-term Debt | 1.6B | 2.9B | 3.2B | 1.9B | 1.0B |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 70.7M | 300.0K | 300.0K | 11.7M | 14.9M |
Total Current Liabilities | 3.0B | 4.4B | 4.3B | 3.2B | 1.8B |
Non-Current Liabilities | |||||
Long-term Debt | 649.2M | 391.5M | 944.2M | 663.1M | 797.1M |
Deferred Tax Liabilities | - | 0 | 5.0M | 15.6M | 21.5M |
Other Non-Current Liabilities | -2.0K | - | -1.0K | - | -1.0K |
Total Non-Current Liabilities | 699.0M | 452.9M | 963.7M | 705.4M | 846.5M |
Total Liabilities | 3.7B | 4.9B | 5.3B | 3.9B | 2.7B |
Equity | |||||
Common Stock | 157.9M | 138.0M | 138.0M | 138.0M | 138.0M |
Retained Earnings | - | 2.7B | 3.5B | 3.2B | 2.5B |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 4.7B | 2.8B | 3.7B | 3.3B | 2.6B |
Key Metrics | |||||
Total Debt | 2.2B | 3.3B | 4.2B | 2.6B | 1.8B |
Working Capital | 2.6B | 286.2M | 668.0M | 762.4M | 757.6M |
Balance Sheet Composition
Bajaj Healthcare Cash Flow Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 420.0M | -1.0B | 582.2M | 896.8M | 1.2B |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | - | - | - | - | - |
Working Capital Changes | -622.1M | 385.1M | -1.2B | -1.1B | -640.9M |
Operating Cash Flow | 13.9M | 205.2M | -439.1M | -87.0M | 628.6M |
Investing Activities | |||||
Capital Expenditures | -114.3M | -190.4M | -930.7M | -741.9M | -1.1B |
Acquisitions | - | - | - | - | - |
Investment Purchases | -28.0M | - | - | - | - |
Investment Sales | - | 67.2M | 0 | 0 | 50.0M |
Investing Cash Flow | -153.2M | -115.6M | -936.6M | -749.7M | -1.1B |
Financing Activities | |||||
Share Repurchases | - | - | - | - | - |
Dividends Paid | -27.6M | -27.6M | -41.4M | -13.8M | -24.1M |
Debt Issuance | 450.0M | - | - | - | - |
Debt Repayment | -189.1M | - | - | - | - |
Financing Cash Flow | 216.6M | -359.2M | 1.1B | 863.5M | 280.2M |
Free Cash Flow | 100.8M | 620.1M | -1.2B | -786.2M | -702.3M |
Net Change in Cash | 77.3M | -269.7M | -275.4M | 26.8M | -182.3M |
Cash Flow Trend
Bajaj Healthcare Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
29.44
Price to Book
3.01
Price to Sales
2.53
PEG Ratio
0.66
Profitability Ratios
Profit Margin
7.90%
Operating Margin
12.68%
Return on Equity
8.47%
Return on Assets
4.74%
Financial Health
Current Ratio
1.89
Debt to Equity
47.89
Beta
0.07
Per Share Data
EPS (TTM)
₹15.10
Book Value per Share
₹147.63
Revenue per Share
₹181.88
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
bajajhcare | 14.2B | 29.44 | 3.01 | 8.47% | 7.90% | 47.89 |
Sun Pharmaceutical | 3.9T | 37.88 | 5.45 | 15.08% | 19.29% | 3.26 |
Divi's Laboratories | 1.6T | 70.79 | 10.93 | 14.64% | 23.89% | 0.03 |
Sun Pharma Advanced | 45.5B | -13.34 | -21.04 | 157.88% | -53.22% | -1.24 |
Aarti Drugs | 44.8B | 23.75 | 3.28 | 12.28% | 7.80% | 44.92 |
Sequent Scientific | 43.9B | 154.18 | 6.24 | 2.84% | 1.85% | 62.47 |
Financial data is updated regularly. All figures are in the company's reporting currency.